Kapitalmarkt

Steuern

Homburger News

Share-Image Teamplate Deals-and-Cases

On May 28, 2024, UBS Switzerland AG successfully completed its issuance of Digital Covered Bonds under the program in an aggregate principal amount of CHF 150 m, consisting of CHF 150 m 1.5075% Digital Covered Bonds due May 2029. The Covered Bonds are governed by Swiss law and are listed on SIX Swiss Exchange and SDX Trading. The Covered Bonds are indirectly backed by a portfolio of mortgages from UBS Switzerland AG&#8217;s domestic mortgage pool.
The Homburger team was led by Stefan Kramer and Benedikt Maurenbrecher and included Daniel Hulmann, Sofiya Shavlak, Michelle Wolf (all Capital Markets) and Stefan Oesterhelt (Tax).

Homburger advised UBS Switzerland AG  on the issuance of CHF 150 m Digital Fixed Rate Covered Bonds

On May 21, 2024, UBS Switzerland AG successfully completed its issuance of Covered Bonds under the program in an aggregate principal amount of EUR 1.75 bn, consisting of EUR 1 bn Floating Rate Covered Bonds due April 2027 and EUR 750 m 3.146% Covered Bonds due 21 June 2031. The Covered Bonds are governed by Swiss law and are listed on SIX Swiss Exchange. The Covered Bonds are indirectly backed by a portfolio of mortgages from UBS Switzerland AG’s domestic mortgage pool.
Homburger advised UBS Switzerland AG as issuer and UBS Hypotheken Schweiz AG as guarantor in respect of all transactional, regulatory and tax aspects of Swiss law. The Homburger team was jointly led by Stefan Kramer and Benedikt Maurenbrecher and included Daniel Hulmann, Sofiya Shavlak and Michelle Wolf (all Capital Markets) as well as Stefan Oesterhelt (Tax).

Homburger advised UBS Switzerland AG on the issuance of EUR 1.75 bn Covered Bonds

Gesellschaftsrecht / M&A

Finanzierungen und Anlageprodukte

IP / IT

Santhera

Homburger and Santhera

On June 18, 2024, Santhera Pharmaceuticals Holding AG (SIX: SANN) announced that it had entered into a royalty monetization financing totaling up to USD 38 m with R-Bridge, an affiliate of CBC Group, Asia&#8217;s largest healthcare-focused investment firm. Santhera is monetizing 75% of its future royalty income streams from its North America and Greater China outlicensing of its marketed product AGAMREE®. In addition, Santhera entered into a commitment letter for a CHF 35 m senior secured term loan financing with certain funds managed by Highbridge Capital. The transaction also includes changes to existing financing arrangements with Highbridge Capital as well as tie issuance of warrants to Highbridge Capital.
Homburger advised Santhera on the Swiss law and tax aspects of the transaction. The Homburger team was led by Daniel Häusermann (Corporate / M&amp;A, Capital Markets) and included Eduard De Zordi, Laura Müller and Michelle Wolf (all Financing and Investment Products, Capital Markets), Stefan Oesterhelt (Tax), Gregor Bühler and Joel Fink (IP / IT), Jasmin Künzle (Corporate / M&amp;A, Capital Markets). Ropes &amp; Gray acted as U.S. counsel to Santhera.

Homburger advised Santhera in connection with its up to CHF 69 m Royalty and Debt Financing

Michelle
Wolf

Homburger advised UBS Switzerland AG on the issuance of CHF 150 m Digital Fixed Rate Covered Bonds

Homburger advised UBS Switzerland AG on the issuance of EUR 1.75 bn Covered Bonds

Homburger advised Santhera in connection with its up to CHF 69 m Royalty and Debt Financing

Join the Team

Michelle Wolf

Karriere

Sprachen

Zulassung

Teams

MichelleWolf

Homburger advised UBS Switzerland AG on the issuance of CHF 150 m Digital Fixed Rate Covered Bonds

Homburger advised UBS Switzerland AG on the issuance of EUR 1.75 bn Covered Bonds

Homburger advised Santhera in connection with its up to CHF 69 m Royalty and Debt Financing

Join the Team

Michelle Wolf

Karriere

Sprachen

Zulassung

Teams

Michelle
Wolf